• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GATA3 是一种有用的免疫组织化学标志物,可用于区分肉瘤样恶性间皮瘤与肺肉瘤样癌和特发性胸膜间皮瘤。

GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.

机构信息

Department of Pathology, Ningbo Diagnostic Pathology Center, Huan Cheng Bei Lu, Jiang Bei District, Ningbo, 315000, Zhejiang, China.

出版信息

Virchows Arch. 2021 Aug;479(2):257-263. doi: 10.1007/s00428-021-03048-y. Epub 2021 Feb 11.

DOI:10.1007/s00428-021-03048-y
PMID:33570661
Abstract

Sarcomatoid malignant mesothelioma (SMM) tends to occur in the pleura and is morphologically similar to lung sarcomatoid carcinoma (LSC) and organizing pleuritis (OP). Because SMM often does not express mesothelial markers, it is very difficult to distinguish from LSC and OP. GATA-binding protein 3 (GATA3) is a specific immunohistochemical (IHC) marker of breast and urothelial carcinoma. We routinely find that GATA is expressed in MM; however, GATA3 expression in SMM and its reference value for distinguishing SMM from LSC and OP remain unclear. Here, we used IHC methods to detect the expression of GATA3 and classic mesothelial markers in 17 SMM, 12 LSC, and 7 OP cases. We detected the following expression rates in SMM versus LSC cases: GATA3 (70.6% vs. 16.7%, p = 0.008), calretinin (52.9% vs. 8.3%, p = 0.019), Wilms tumor (WT)-1 (64.7% vs. 0%, p = 0.000), D2-40 (47.1% vs. 16.7%, p = 0.126), CK5/6 (35.3% vs. 25.0%, p = 0.694), and pan-cytokeratin (CKpan) (88.2% vs. 100.0%, p = 0.498). The specificities of calretinin, WT-1, and GATA3 in distinguishing SMM from LSC were 91.7%, 100%, and 83.3%, respectively, and combinations of any two of these three markers exhibited 100% specificity for SMM. Notably, the sensitivity of calretinin+/WT1+ staining for SMM was only 23.5%, which increased to 64.7% after including GATA3. Furthermore, all OP cases showed partial or diffuse expression of CKpan, WT-1, and D2-40 but no GATA3 and calretinin expression. In conclusion, GATA3 is an IHC marker with excellent sensitivity and specificity for SMM, and the combined consideration of GATA3, calretinin, and WT-1 was best for distinguishing SMM from LSC. Moreover, CKpan, WT-1, and D2-40 had no value for distinguishing SMM from OP, and GATA3 and calretinin were the most specific markers for distinguishing these two lesions.

摘要

肉瘤样恶性间皮瘤(SMM)倾向于发生在胸膜,形态上类似于肺肉瘤样癌(LSC)和机化性胸膜炎(OP)。由于 SMM 通常不表达间皮标志物,因此很难将其与 LSC 和 OP 区分开来。GATA 结合蛋白 3(GATA3)是乳腺和尿路上皮癌的一种特定免疫组织化学(IHC)标志物。我们经常发现 GATA 在 MM 中表达;然而,SMM 中 GATA3 的表达及其用于区分 SMM 与 LSC 和 OP 的参考价值尚不清楚。在这里,我们使用 IHC 方法检测了 17 例 SMM、12 例 LSC 和 7 例 OP 病例中 GATA3 和经典间皮标志物的表达。我们在 SMM 与 LSC 病例中检测到以下表达率:GATA3(70.6% vs. 16.7%,p=0.008)、钙视网膜蛋白(52.9% vs. 8.3%,p=0.019)、Wilms 肿瘤(WT)-1(64.7% vs. 0%,p=0.000)、D2-40(47.1% vs. 16.7%,p=0.126)、CK5/6(35.3% vs. 25.0%,p=0.694)和 pan-cytokeratin(CKpan)(88.2% vs. 100.0%,p=0.498)。钙视网膜蛋白、WT-1 和 GATA3 在区分 SMM 与 LSC 方面的特异性分别为 91.7%、100%和 83.3%,这三种标志物中的任意两种组合在区分 SMM 方面均具有 100%的特异性。值得注意的是,钙视网膜蛋白+/WT1+染色对 SMM 的敏感性仅为 23.5%,而包含 GATA3 后则增加到 64.7%。此外,所有 OP 病例均表现为 CKpan、WT-1 和 D2-40 的部分或弥漫表达,但无 GATA3 和钙视网膜蛋白表达。总之,GATA3 是一种用于 SMM 的具有优异敏感性和特异性的 IHC 标志物,考虑 GATA3、钙视网膜蛋白和 WT-1 的联合使用最有利于区分 SMM 与 LSC。此外,CKpan、WT-1 和 D2-40 对区分 SMM 与 OP 没有价值,而 GATA3 和钙视网膜蛋白是区分这两种病变的最特异标志物。

相似文献

1
GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.GATA3 是一种有用的免疫组织化学标志物,可用于区分肉瘤样恶性间皮瘤与肺肉瘤样癌和特发性胸膜间皮瘤。
Virchows Arch. 2021 Aug;479(2):257-263. doi: 10.1007/s00428-021-03048-y. Epub 2021 Feb 11.
2
GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.GATA3 免疫组化在鉴别肉瘤样间皮瘤和促纤维增生性间皮瘤与肺肉瘤样癌中的作用。
Am J Surg Pathol. 2017 Sep;41(9):1221-1225. doi: 10.1097/PAS.0000000000000825.
3
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.胸膜肉瘤样间皮瘤与肺梭形细胞/多形性(肉瘤样)癌的鉴别诊断:国际间皮瘤小组和MESOPATH国家参考中心的循证指南
Hum Pathol. 2017 Sep;67:160-168. doi: 10.1016/j.humpath.2017.07.015. Epub 2017 Aug 4.
4
The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.GATA 结合蛋白 3 在恶性胸膜间皮瘤诊断中的潜在应用。
Hum Pathol. 2020 Nov;105:1-8. doi: 10.1016/j.humpath.2020.08.005. Epub 2020 Sep 2.
5
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.MTAP 和 BAP1 免疫组化联合检测可有效鉴别肉瘤样间皮瘤与纤维性胸膜炎。
Lung Cancer. 2018 Nov;125:198-204. doi: 10.1016/j.lungcan.2018.09.019. Epub 2018 Sep 26.
6
[Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].[肉瘤样恶性间皮瘤:22例临床病理及免疫组化分析]
Zhonghua Bing Li Xue Za Zhi. 2014 Jun;43(6):364-9.
7
Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.肉瘤样间皮瘤及其他梭形细胞肿瘤中的抗间皮细胞标志物
Histopathology. 2000 Sep;37(3):224-31. doi: 10.1046/j.1365-2559.2000.00981.x.
8
Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.免疫组织化学检测 MUC4 和 GATA3 对胸膜肉瘤样间皮瘤与肺肉瘤样癌鉴别的应用价值。
Arch Pathol Lab Med. 2021 Feb 1;145(2):208-213. doi: 10.5858/arpa.2019-0647-OA.
9
Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.肉瘤样间皮瘤及其组织学模拟物:一项比较性免疫组织化学研究。
Histopathology. 2003 Mar;42(3):270-9. doi: 10.1046/j.1365-2559.2003.01583.x.
10
[Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].[胸膜外肉瘤样间皮瘤的临床及病理特征]
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):559-564. doi: 10.3760/cma.j.issn.0529-5807.2017.08.008.

引用本文的文献

1
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities.胸膜间皮瘤的分子见解:揭示致病机制与治疗机遇
Diagnostics (Basel). 2025 May 24;15(11):1323. doi: 10.3390/diagnostics15111323.
2
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
3
A Comprehensive Review of TRPS1 as a Diagnostic Immunohistochemical Marker for Primary Breast Carcinoma: Latest Insights and Diagnostic Pitfalls.

本文引用的文献

1
The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.GATA 结合蛋白 3 在恶性胸膜间皮瘤诊断中的潜在应用。
Hum Pathol. 2020 Nov;105:1-8. doi: 10.1016/j.humpath.2020.08.005. Epub 2020 Sep 2.
2
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.恶性间皮瘤病理诊断指南:国际间皮瘤兴趣小组共识声明2017年更新版
Arch Pathol Lab Med. 2018 Jan;142(1):89-108. doi: 10.5858/arpa.2017-0124-RA. Epub 2017 Jul 7.
3
Improving the Accuracy of Mesothelioma Diagnosis in China.
TRPS1作为原发性乳腺癌诊断性免疫组化标志物的综合综述:最新见解与诊断陷阱
Cancers (Basel). 2024 Oct 23;16(21):3568. doi: 10.3390/cancers16213568.
4
A Case of GATA3 Positive Pleomorphic Liposarcoma, Epithelioid Variant: A Diagnostic Pitfall.1例GATA3阳性多形性脂肪肉瘤,上皮样变型:诊断陷阱
Case Rep Pathol. 2023 Mar 24;2023:9443027. doi: 10.1155/2023/9443027. eCollection 2023.
5
Immunohistochemistry for Claudin-4 and BAP1 in the Differential Diagnosis between Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma.Claudin-4和BAP1免疫组化在肉瘤样癌与肉瘤样间皮瘤鉴别诊断中的应用
Diagnostics (Basel). 2023 Jan 9;13(2):249. doi: 10.3390/diagnostics13020249.
提高中国间皮瘤诊断的准确性。
J Thorac Oncol. 2017 Apr;12(4):714-723. doi: 10.1016/j.jtho.2016.12.006. Epub 2016 Dec 19.
4
GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas.GATA3表达是软组织肉瘤的不良预后因素。
PLoS One. 2016 Jun 1;11(6):e0156524. doi: 10.1371/journal.pone.0156524. eCollection 2016.
5
Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.应用 PAX8 和 GATA3 诊断梭形细胞肾细胞癌和梭形细胞尿路上皮癌。
Hum Pathol. 2013 Aug;44(8):1563-8. doi: 10.1016/j.humpath.2012.12.012. Epub 2013 Feb 28.
6
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.肉瘤样间皮瘤:326 例临床病理学相关性研究。
Mod Pathol. 2010 Mar;23(3):470-9. doi: 10.1038/modpathol.2009.180. Epub 2010 Jan 15.
7
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.免疫组织化学在胸膜肉瘤样间皮瘤与肺肉瘤样癌鉴别诊断中的价值
Histopathology. 2009 May;54(6):667-76. doi: 10.1111/j.1365-2559.2009.03298.x.
8
Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.运用免疫组织化学方法对肉瘤样间皮瘤与真性肉瘤及肉瘤样癌进行鉴别诊断。
Pathol Int. 2008 Feb;58(2):75-83. doi: 10.1111/j.1440-1827.2007.02193.x.
9
D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.D2-40和钙视网膜蛋白——341例恶性间皮瘤的组织芯片分析,重点关注肉瘤样分化
Mod Pathol. 2007 Feb;20(2):248-55. doi: 10.1038/modpathol.3800736.
10
Spindle cell tumors of the pleura: differential diagnosis.胸膜的梭形细胞肿瘤:鉴别诊断
Semin Diagn Pathol. 2006 Feb;23(1):44-55. doi: 10.1053/j.semdp.2006.06.002.